MAPT and Alzheimer disease: Aβ oligomers are known to be increased in the early stages of AD and to attack neurons [60], while also inducing Tau hyperphosphorylation [61], namely, at serine residues 396 and 404 [62], that contribute to microtubule and synapse dysfunctions [63].